Study of rezafungin for suspected fungal infection in the abdomen
Part of Infections clinical trials.
This trial is testing how the body processes the antifungal drug rezafungin in people who may have a fungal infection in their abdomen (peritonitis or intra-abdominal candidiasis). It aims to understand how the drug works and if it can help when other antibiotics haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have signs of an infection in your abdomen (like peritonitis) that hasn't improved after at least 48 hours of antibiotics
- You have a drainage tube in your abdomen that can provide fluid samples
- You are not allergic to rezafungin or any similar antifungal drugs
- You are not currently taking other antifungal medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well rezafungin, an antifungal medicine, spreads in belly fluid when given during surgery for a suspected fungal infection in the abdomen. It aims to see if it's a good treatment option for patients needing abdominal surgery.
This trial tests whether a medicine called rezafungin can help prevent serious fungal infections in people who have received a liver transplant. If you have certain risk factors, this study may offer extra protection against infections.
This Phase 2 trial tests rezafungin, an antifungal medicine, to treat Pneumocystis pneumonia (PCP) in adults living with HIV. It may help people recover faster or more effectively from this serious lung infection.
This Phase 3 trial studies whether caspofungin (an antifungal medicine) helps treat suspected or confirmed yeast (candidiasis) infections inside the abdomen in ICU patients after surgery. You would either receive caspofungin or a placebo, and the goal is to see which option works better and is safe.
This study looks at how Candida infections form biofilms (protective coatings) and resist antifungal treatments. It may help find better ways to treat serious Candida infections in people with weakened immune systems or after medical procedures.
This trial tests a new antifungal drug, HRS9432, for patients with candidemia (a yeast infection in the blood) or invasive candidiasis (yeast infection in organs). It aims to see if the drug is safe and works well for these serious infections.
Hear when a new Candidal Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.